Dov Elefant

Dov S.
Elefant currently works at Femasys, Inc., as Chief Financial Officer from 2022.
Mr. Elefant also formerly worked at Tetragenex Pharmaceuticals, Inc., as Director-Accounting & Finance from 1999 to 2007, Synvista Therapeutics, Inc., as Assistant Controller from 1998 to 1999, Celsus Therapeutics Plc, as Chief Operating & Financial Officer from 2013 to 2015, Althera Medical Ltd., as Chief Financial Officer, Lev Pharmaceuticals, Inc., as Controller from 2007 to 2009, EpiCept Corp., as Controller, VP-Finance & Administration from 1999 to 2007, Cellectar Biosciences, Inc., as Chief Financial Officer & Vice President from 2019 to 2022, and Akari Therapeutics Plc, as Chief Financial Officer from 2012 to 2019.
Mr. Elefant received his undergraduate degree from Sy Syms School of Business.